par de Azambuja, Evandro ;Zardavas, Dimitros ;Lemort, Marc ;Rossari, José ;Moulin, C;Buttice, A;D'Hondt, Veronique ;Lebrun, Fabienne;Lalami, Yassine ;Cardoso, Fatima ;Sotiriou, Christos ;Gil, Thierry ;Devriendt, Daniel ;Paesmans, M.;Piccart-Gebhart, Martine ;Awada, Ahmad
Référence Annals of oncology, 24, 12, page (2985-2989)
Publication Publié, 2013-12
Référence Annals of oncology, 24, 12, page (2985-2989)
Publication Publié, 2013-12
Article révisé par les pairs
Résumé : | Brain metastases (BMs) pose a clinical challenge in breast cancer (BC). Lapatinib or temozolomide showed activity in BM. Our study assessed the combination of both drugs as treatment for patients with HER2-positive BC and BM. |